FUSE GROUP HOLDING INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FUSE GROUP HOLDING INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $45.9K | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | $332.0K | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | $0 | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $200.0K | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $700.0K | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | $750.0K | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | $1.22M | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | $0 | Jan 14, 2020 |
| FY2017 | Sep 30, 2017 | $0 | May 23, 2018 |
| FY2017 | Sep 30, 2016 | $25.2K | May 23, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $45.9K | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | $332.0K | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | $0 | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $190.0K | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $618.9K | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | $548.5K | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | $938.6K | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | $0 | Jan 14, 2020 |
| FY2017 | Sep 30, 2017 | $0 | May 23, 2018 |
| FY2017 | Sep 30, 2016 | $18.1K | May 23, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($283.7K) | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | ($40.4K) | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | ($474.8K) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($444.5K) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | ($1.02M) | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | ($51.4K) | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | ($79.7K) | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | ($4.22M) | Jan 14, 2020 |
| FY2018 | Sep 30, 2017 | ($1.56M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($43.1K) | May 23, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($277.9K) | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | ($33.4K) | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | ($455.1K) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($433.7K) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | ($1.07M) | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | ($45.3K) | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | ($77.8K) | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | ($4.10M) | Jan 14, 2020 |
| FY2018 | Sep 30, 2017 | ($1.52M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($43.1K) | May 23, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | $1.50M | Dec 31, 2018 |
| FY2018 | Sep 30, 2017 | $0 | Dec 31, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($289.9K) | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | ($60.0K) | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | ($439.8K) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($449.8K) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | ($58.4K) | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | ($62.8K) | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | ($1.2K) | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | ($4.24M) | Jan 14, 2020 |
| FY2018 | Sep 30, 2017 | ($2.52M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($40.7K) | May 23, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $14.6K | May 23, 2018 |
| FY2017 | Sep 30, 2016 | $0 | May 23, 2018 |
| FY2016 | Sep 30, 2015 | ($4.4K) | Nov 17, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $34.7K | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | $85.4K | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | $72.2K | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $106.1K | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $165.0K | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | $1.24M | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | $1.11M | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | $1.19M | Jan 14, 2020 |
| FY2018 | Sep 30, 2017 | $5.36M | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | $19.0K | May 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $485.2K | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | $252.2K | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | $250.0K | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $525.8K | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $140.3K | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | $191.1K | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | $10.7K | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | $9.6K | Jan 14, 2020 |
| FY2018 | Sep 30, 2017 | $6.88M | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | $35.1K | May 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($450.5K) | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | ($166.8K) | Dec 29, 2025 |
| FY2025 | Sep 30, 2023 | ($177.8K) | Dec 29, 2025 |
| FY2024 | Sep 30, 2022 | ($419.7K) | Dec 26, 2024 |
| FY2023 | Sep 30, 2021 | $24.8K | Dec 27, 2023 |
| FY2022 | Sep 30, 2020 | $1.05M | Dec 29, 2022 |
| FY2021 | Sep 30, 2019 | $1.10M | Feb 11, 2022 |
| FY2020 | Sep 30, 2018 | $1.18M | Dec 16, 2020 |
| FY2019 | Sep 30, 2017 | ($1.52M) | Jan 14, 2020 |
| FY2018 | Sep 30, 2016 | ($16.2K) | Dec 31, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($8.23M) | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | ($7.95M) | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | ($7.91M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($7.43M) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | ($6.99M) | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | ($5.97M) | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | ($5.91M) | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | ($5.83M) | Jan 14, 2020 |
| FY2018 | Sep 30, 2017 | ($1.61M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($57.0K) | May 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $21.2K | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | $67.6K | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | $26.6K | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $33.0K | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $135.5K | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | $194.5K | Feb 11, 2022 |
| FY2021 | Sep 30, 2019 | $102.2K | Feb 11, 2022 |
| FY2020 | Sep 30, 2018 | $103.4K | Dec 16, 2020 |
| FY2019 | Sep 30, 2017 | $419.1K | Jan 14, 2020 |
| FY2018 | Sep 30, 2016 | $8.2K | Dec 31, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $97.5K | Dec 29, 2025 |
| FY2024 | Sep 30, 2024 | $101.2K | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | $103.7K | Dec 27, 2023 |
| FY2022 | Sep 30, 2022 | $106.3K | Dec 29, 2022 |
| FY2021 | Sep 30, 2021 | $109.0K | Feb 11, 2022 |
| FY2020 | Sep 30, 2020 | $156.1K | Dec 16, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 26, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 29, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 13.30M | Dec 29, 2025 |
| FY2025 | Sep 30, 2024 | 13.30M | Dec 29, 2025 |
| FY2025 | Sep 19, 2024 | 75.00M | Dec 29, 2025 |
| FY2025 | Sep 18, 2024 | 375.00M | Dec 29, 2025 |
| FY2024 | Sep 30, 2023 | 13.27M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | 64.78M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | 64.78M | Dec 29, 2022 |
| FY2021 | Sep 30, 2020 | 64.78M | Feb 11, 2022 |
| FY2020 | Sep 30, 2019 | 64.78M | Dec 16, 2020 |
| FY2019 | Sep 30, 2018 | 64.78M | Jan 14, 2020 |